What is the maximum individual dose of potassium chloride, broken down between potassium tablets (K Tab) and potassium chloride extended-release tablets (Klor-Con, potassium chloride)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION ... Dosage should be divided if more than 20 mEq per day is given such that no more than 20 mEq is given in a single dose. Each potassium chloride extended-release tablet, USP 20 mEq provides 20 mEq of potassium Each potassium chloride extended-release tablet, USP 10 mEq provides 10 mEq of potassium.

The maximum individual dose of potassium chloride is 20 mEq per dose. This can be achieved with:

  • 1 x potassium chloride extended-release tablet, USP 20 mEq
  • 2 x potassium chloride extended-release tablet, USP 10 mEq
  • 1 x potassium chloride tablet, USP (broken in half is allowed, but still not more than 20 mEq) 1

From the Research

The maximum individual dose of potassium chloride is typically 20 mEq per dose for both K-Tab and Klor-Con formulations, with a total daily dose not exceeding 100 mEq, as supported by the most recent and highest quality study available 2. When considering oral potassium supplementation, it's essential to differentiate between immediate-release and extended-release formulations. K-Tab is often available as 10 mEq tablets, while Klor-Con comes in various extended-release formulations (8 mEq, 10 mEq, and 20 mEq).

  • Key considerations for potassium supplementation include:
    • Taking medications with a full glass of water or with food to minimize gastrointestinal irritation
    • Avoiding crushing or chewing extended-release formulations to prevent rapid potassium release and potential cardiac toxicity
    • Careful monitoring, especially in patients with renal impairment, as hyperkalemia can cause dangerous cardiac arrhythmias
    • Regularly checking serum potassium levels to ensure they remain within the normal range of 3.5-5.0 mEq/L, as noted in studies such as 3 and 4. The importance of careful monitoring and appropriate dosing is further emphasized by older studies, such as 5 and 6, which highlight the therapeutic equivalency of different potassium chloride formulations and the safety of concentrated infusions in critically ill patients, respectively. However, the most recent and highest quality evidence, such as 2, should be prioritized when making clinical decisions regarding potassium chloride dosing.
  • Important factors to consider when selecting a potassium supplement include:
    • The patient's individual needs and medical history
    • The potential for drug interactions and side effects
    • The importance of patient education and compliance with prescribed dosing regimens.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.